Recent Updates
Recently added Catalysts
MDXG Positive Sentiment

MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30

Key Takeaway: MiMedx Group, Inc. (MDXG) announced that it will report its third quarter operating and financial results on October 30, 2023. Following the results, the company will host a conference call and webcast at 4:30 p.m. ET to discuss these outcomes. The event will provide insights into the company’s performance, particularly in the wound care sector, demonstrating their ongoing commitment to innovation in healing solutions.
Price reaction · baseline $6.34 (2023-10-13 close) · clean, no other MDXG news in the window
day 0 close · peak
+1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • MIMEDX continues to establish itself as a leader in wound care solutions.
  • The upcoming conference call provides an opportunity to review significant milestones.
  • MIMEDX's focus on innovation aligns with improving quality of life for patients.
  • The company's commitment to helping clinicians manage chronic wounds reflects a strong market position.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~40 mo
Low dilution risk
Lead asset
Micronized DHACM
Phase 3 · Tendonitis;Achilles

Full Press Release Details

MARIETTA, Ga., Oct. 16, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2023 after the market close on Monday, October 30, 2023. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13741654
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Frequently Asked Questions

When will MiMedx report its Q3 2023 financial results?

MiMedx will report its Q3 2023 results on October 30, 2023, after market close.

What time is the MiMedx conference call for Q3 results?

The conference call for Q3 results is scheduled for 4:30 p.m. ET on October 30.

How can I access the MiMedx conference call?

U.S. investors can call 877-407-6184; international investors can dial 201-389-0877.

Where can I find the MiMedx webcast replay?

The webcast replay will be available for 30 days on MiMedx's website post-event.

What is MiMedx known for?

MiMedx specializes in healing solutions for chronic wounds, burns, and surgery.

Last updated: Oct 16, 2023